Clinical Trial Update: A First-in-human Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women [Phase 1]

View source ↗

Summary

A first-in-human Phase 1 study of AMG 167 in healthy men and postmenopausal women with osteopenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteopenia

Drugs mentioned

• AMG 167

Snippet

Sponsor: Amgen | Conditions: Osteopenia | Phase 1 | Status: COMPLETED